Literature DB >> 19351938

Risk of venous thromboembolism with bevacizumab in cancer patients.

Saadettin Kilickap, Cagatay Arslan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19351938     DOI： 10.1001/jama.2009.441

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  2 in total

Review 1.  The double edged sword of bleeding and clotting from VEGF inhibition in renal cancer patients.

Authors:  Guru Sonpavde; Joaquim Bellmunt; Fabio Schutz; Toni K Choueiri
Journal:  Curr Oncol Rep       Date:  2012-08       Impact factor: 5.075

Review 2.  Kinase inhibitors and monoclonal antibodies in oncology: clinical implications.

Authors:  Helen Gharwan; Hunter Groninger
Journal:  Nat Rev Clin Oncol       Date:  2015-12-31       Impact factor: 66.675
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.